These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10599652)

  • 1. A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD Study). Radiation Therapy for Age-related Macular Degeneration.
    Ophthalmology; 1999 Dec; 106(12):2239-47. PubMed ID: 10599652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External beam irradiation of subfoveal choroidal neovascularization complicating age-related macular degeneration: one-year results of a prospective, double-masked, randomized clinical trial.
    Marcus DM; Sheils W; Johnson MH; McIntosh SB; Leibach DB; Maguire A; Alexander J; Samy CN
    Arch Ophthalmol; 2001 Feb; 119(2):171-80. PubMed ID: 11176977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual outcomes in the subfoveal radiotherapy study: a randomized controlled trial of teletherapy for age-related macular degeneration.
    Hart PM; Chakravarthy U; Mackenzie G; Chisholm IH; Bird AC; Stevenson MR; Owens SL; Hall V; Houston RF; McCulloch DW; Plowman N
    Arch Ophthalmol; 2002 Aug; 120(8):1029-38. PubMed ID: 12149056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy for subfoveal choroidal neovascularization in age-related macular degeneration: a randomized clinical trial.
    Valmaggia C; Ries G; Ballinari P
    Am J Ophthalmol; 2002 Apr; 133(4):521-9. PubMed ID: 11931786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.
    Verteporfin In Photodynamic Therapy Study Group
    Am J Ophthalmol; 2001 May; 131(5):541-60. PubMed ID: 11336929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twelve-month safety and visual acuity results from a feasibility study of intraocular, epiretinal radiation therapy for the treatment of subfoveal CNV secondary to AMD.
    Avila MP; Farah ME; Santos A; Kapran Z; Duprat JP; Woodward BW; Nau J
    Retina; 2009 Feb; 29(2):157-69. PubMed ID: 19202425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation therapy for subfoveal choroidal neovascular membranes in age-related macular degeneration. A pilot study.
    Bergink GJ; Deutman AF; van den Broek JF; van Daal WA; van der Maazen RW
    Graefes Arch Clin Exp Ophthalmol; 1994 Oct; 232(10):591-8. PubMed ID: 7528158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 5-year follow-up study for distance visual acuity after low dose radiation on subfoveal choroidal neovascularization in age-related macular degeneration.
    Valmaggia C; Ries G; Ballinari P
    Doc Ophthalmol; 2001 Nov; 103(3):201-9. PubMed ID: 11824657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The age-related macular degeneration radiotherapy trial (AMDRT): one year results from a pilot study.
    Marcus DM; Peskin E; Maguire M; Weissgold D; Alexander J; Fine S; Followill D;
    Am J Ophthalmol; 2004 Nov; 138(5):818-28. PubMed ID: 15531318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External beam radiation therapy for choroidal neovascularization.
    Spaide RF; Guyer DR; McCormick B; Yannuzzi LA; Burke K; Mendelsohn M; Haas A; Slakter JS; Sorenson JA; Fisher YL; Abramson D
    Ophthalmology; 1998 Jan; 105(1):24-30. PubMed ID: 9442775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.
    Azab M; Boyer DS; Bressler NM; Bressler SB; Cihelkova I; Hao Y; Immonen I; Lim JI; Menchini U; Naor J; Potter MJ; Reaves A; Rosenfeld PJ; Slakter JS; Soucek P; Strong HA; Wenkstern A; Su XY; Yang YC;
    Arch Ophthalmol; 2005 Apr; 123(4):448-57. PubMed ID: 15824216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.
    Bressler NM; Arnold J; Benchaboune M; Blumenkranz MS; Fish GE; Gragoudas ES; Lewis H; Schmidt-Erfurth U; Slakter JS; Bressler SB; Manos K; Hao Y; Hayes L; Koester J; Reaves A; Strong HA;
    Arch Ophthalmol; 2002 Nov; 120(11):1443-54. PubMed ID: 12427056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radiotherapy for choroidal neovascularization (CNV) in age-related macular degeneration (AMD)].
    Thölen AM; Meister A; Bernasconi PP; Messmer EP
    Klin Monbl Augenheilkd; 2000 Feb; 216(2):112-5. PubMed ID: 10730228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy for recurrent choroidal neovascularisation complicating age related macular degeneration.
    Marcus DM; Sheils WC; Young JO; McIntosh SB; Johnson MH; Alexander J; Samy CN
    Br J Ophthalmol; 2004 Jan; 88(1):114-9. PubMed ID: 14693787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled clinical trial on the efficacy of radiation therapy in the control of subfoveal choroidal neovascularization in age-related macular degeneration: radiation versus observation.
    Bergink GJ; Hoyng CB; van der Maazen RW; Vingerling JR; van Daal WA; Deutman AF
    Graefes Arch Clin Exp Ophthalmol; 1998 May; 236(5):321-5. PubMed ID: 9602314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.
    Bressler NM;
    Arch Ophthalmol; 2001 Feb; 119(2):198-207. PubMed ID: 11176980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occult with no classic subfoveal choroidal neovascular lesions in age-related macular degeneration: clinically relevant natural history information in larger lesions with good vision from the Verteporfin in Photodynamic Therapy (VIP) Trial: VIP Report No. 4.
    Pieramici DJ; Bressler SB; Koester JM; Bressler NM
    Arch Ophthalmol; 2006 May; 124(5):660-4. PubMed ID: 16682587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy for age-related macular degeneration: is there a benefit for classic CNV?
    Eter N; Schüller H; Spitznas M
    Int Ophthalmol; 2001; 24(1):13-9. PubMed ID: 11998881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The photon therapy of subfoveal choroidal neovascularization in age-dependent macular degeneration. The results of a prospective study in 40 patients].
    Prettenhofer U; Haas A; Mayer R; Oechs A; Pakisch B; Stranzl H; Willfurth P; Hackl A
    Strahlenther Onkol; 1998 Dec; 174(12):613-7. PubMed ID: 9879347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.